Compare McKesson Corporation (MCK) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Shopify Inc. — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while Shopify Inc. trades at $170.85 (market cap $211.73B). The key difference: Shopify Inc. is the larger of the two by market cap, and McKesson Corporation pays a 0.4% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Shopify Inc. for 78 Days on average.
| MCK | SHOP | |
|---|---|---|
Market Cap | $108.46B | $211.73B |
Volume | 712,607 | 7,146,651 |
Sector | Health | Technology |
52-Week High | $995.69 | $179.01 |
52-Week Low | $725.17 | $95.40 |
Typical Hold Time | 74 Days | 78 Days |
Enterprise Value | $115.00B | $206.96B |
Dividend Yield | 0.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $938.84, up 3.13% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
The outlook is positive with 81% analyst buy ratings and a $956.43 consensus price target. Key risks include margin pressure from drug pricing policies and high current liabilities of $61.60B. The stock's valuation at 24.95x P/E appears reasonable given earnings growth projections, but investors should monitor debt levels and regulatory developments in healthcare distribution.
Shopify trades at $164.54, down 0.84% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust revenue growth, increasing from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 111.19. Recent developments include the launch of Canvas AI store builder and strategic moves in AI-powered commerce positioning.
Outlook remains positive with 67% analyst buy ratings and $168.63 consensus target, though high valuation and competitive pressures from Amazon present risks. Operating cash flow growth to $2.4B projected for 2026 supports continued investment in merchant solutions and AI capabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
